Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323868 · ClinicalTrials.gov registry record
Endogenous Endophthalmitis in the Inpatient Setting
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 145
- Enrollment target
NCT01323868: Completed study, sponsored by Stanford University.
NCT01323868 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323868 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-06 |
What the finished NCT01323868 record still lists
NCT01323868 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01323868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01323868 about?
NCT01323868 is a clinical study titled "Endogenous Endophthalmitis in the Inpatient Setting". The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
What is the current status of trial NCT01323868?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2010-07. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01323868?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia